Lin Jin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Hidradenitis Suppurativa

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Molecular carcinogenesis

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Lin Jin, Mahendra P Kashyap, Safiya T Haque, Changzhao Li, Chander Raman, Mohammad Athar
Reply to Nebo et al.: Pathogenesis of advanced hidradenitis suppurativa: Are there differences based on anatomical location, gender, and race? Proceedings of the National Academy of Sciences of the United States of America 121 (23) (2024)
Lin Jin, Mahendra P Kashyap, Safiya T Haque, Changzhao Li, Chander Raman, Mohammad Athar
Reply to Nebo et al.: Pathogenesis of advanced hidradenitis suppurativa: Are there differences based on anatomical location, gender, and race? Proceedings of the National Academy of Sciences of the United States of America 121 (23) (2024)
Mahendra P Kashyap, Bharat K Mishra, Rajesh Sinha, Lin Jin, Nilesh Kumar, Kayla F Goliwas, Jessy S Deshane, Boni E Elewski, Craig A Elmets, Mohammad Athar, M Shahid Mukhtar, Chander Raman
NK and NKT cells in the pathogenesis of Hidradenitis suppurativa: Novel therapeutic strategy through targeting of CD2. bioRxiv : the preprint server for biology (2023)
Lin Jin, Yunjia Chen, Suhail Muzaffar, Chao Li, Carlos A Mier-Aguilar, Jasim Khan, Mahendra P Kashyap, Shanrun Liu, Ritesh Srivastava, Jessy S Deshane, Tim M Townes, Boni E Elewski, Craig A Elmets, David K Crossman, Chander Raman, Mohammad Athar
Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa. Proceedings of the National Academy of Sciences of the United States of America 120 (49) (2023)
Ritesh K Srivastava, Purushotham Guroji, Lin Jin, M Shahid Mukhtar, Mohammad Athar
Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism. Molecular carcinogenesis 61 (8) (2022)